Literature DB >> 1417743

Human interleukin-5 expressed in Escherichia coli has N-terminal modifications.

K Rose1, P O Regamey, R Anderegg, T N Wells, A E Proudfoot.   

Abstract

Recombinant human interleukin-5 exists as four major isoforms all possessing N-terminal methionine. Peptide mapping and subsequent analysis by fast-atom-bombardment mass spectrometry (f.a.b.-m.s.) have shown that N-terminal modifications are the cause of the charge heterogeneity. In order of decreasing abundance, these are unmodified methionine, retention of N-terminal formyl group, oxidation of N-terminal methionine to sulphoxide and carbamoylation of the N-terminus. These results were confirmed by analysis of the reduced and alkylated intact protein by electrospray-ionization mass spectrometry. The implications of these findings for the production and characterization of recombinant proteins are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417743      PMCID: PMC1132978          DOI: 10.1042/bj2860825

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  Purification and characterization of recombinant human interleukin 5 expressed in Chinese hamster ovary cells.

Authors:  M Tsujimoto; H Adachi; S Kodama; N Tsuruoka; Y Yamada; S Tanaka; S Mita; K Takatsu
Journal:  J Biochem       Date:  1989-07       Impact factor: 3.387

2.  The chromatographic determination of cystine and cysteine residues in proteins as s-beta-(4-pyridylethyl)cysteine.

Authors:  M Friedman; L H Krull; J F Cavins
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

3.  Expression of human and murine interleukin-5 in eukaryotic systems.

Authors:  J Tavernier; R Devos; J Van der Heyden; G Hauquier; R Bauden; I Fache; E Kawashima; J Vandekerckhove; R Contreras; W Fiers
Journal:  DNA       Date:  1989-09

4.  Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue.

Authors:  C Azuma; T Tanabe; M Konishi; T Kinashi; T Noma; F Matsuda; Y Yaoita; K Takatsu; L Hammarström; C I Smith
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

5.  Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli.

Authors:  A E Proudfoot; D Fattah; E H Kawashima; A Bernard; P T Wingfield
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

6.  In vitro and in vivo studies with purified recombinant human interleukin 5.

Authors:  D Fattah; D J Quint; A Proudfoot; R O'Malley; E D Zanders; B R Champion
Journal:  Cytokine       Date:  1990-03       Impact factor: 3.861

7.  Purification and physicochemical characterization of murine T cell replacing factor (TRF).

Authors:  K Takatsu; N Harada; Y Hara; Y Takahama; G Yamada; K Dobashi; T Hamaoka
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.

Authors:  E Clutterbuck; J G Shields; J Gordon; S H Smith; A Boyd; R E Callard; H D Campbell; I G Young; C J Sanderson
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

9.  Purification and partial sequence analysis of murine B cell growth factor II (interleukin 5).

Authors:  D T McKenzie; H I Filutowicz; S L Swain; R W Dutton
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

10.  Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5.

Authors:  A Tominaga; T Takahashi; Y Kikuchi; S Mita; S Naomi; N Harada; N Yamaguchi; K Takatsu
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

  10 in total
  1 in total

1.  N-Terminal Methionine Processing.

Authors:  Paul T Wingfield
Journal:  Curr Protoc Protein Sci       Date:  2017-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.